Pharmacogenomics of Cisplatin Sensitivity in Non-small Cell Lung Cancer

Cisplatin, a platinum-based chemotherapeutic drug, has been used for over 30 years in a wide variety of cancers with varying degrees of success. In particular, cisplatin has been used to treat late stage non-small cell lung cancer (NSCLC) as the standard of care. However, therapeutic outcomes vary f...

Descripción completa

Detalles Bibliográficos
Autores principales: Rose, Maimon C., Kostyanovskaya, Elina, Huang, R. Stephanie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4411417/
https://www.ncbi.nlm.nih.gov/pubmed/25449594
http://dx.doi.org/10.1016/j.gpb.2014.10.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4411417/
https://www.ncbi.nlm.nih.gov/pubmed/25449594
http://dx.doi.org/10.1016/j.gpb.2014.10.003

Ejemplares similares